Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealing

24 Apr 2018 17:04

RNS Number : 9918L
Omega Diagnostics Group PLC
24 April 2018
 

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

PDMR Dealing

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 24 April 2018 that Edward Valente, Group R&D Director of the Company has purchased 124,044 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a price of 14.5 pence per Ordinary Share.

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1)

Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')

a)

Name

Edward Valente

2.

Reason for notification

b)

Position / status

Group R&D Director

c)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

b)

Name

Omega Diagnostics Group plc

c)

LEI

2138007U9P4BTZTYIR92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 Identification code

 

Purchase of Ordinary Shares

 GB00B1VCP282

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Volume(s)

Price(s) £

124,044

0.145

 

d)

Aggregated information

Aggregated volume Price

Aggregate Volume(s)

Volume weighted average Price) £

124,044

0.145

 

e)

Date of the transaction

24/04/18

f)

Place of the transaction

LSE

 

Contacts:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Colin King, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

Jag Grewal, Group Sales and Marketing Director

 

 

 

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)

 

Camille Gochez (Corporate Broking)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKQDKABKDBQB
Date   Source Headline
28th Nov 201412:55 pmRNSCorrection: Director's Dealing
28th Nov 201410:35 amRNSDirector's Dealing
28th Nov 20147:00 amRNSDirector's Dealing
26th Nov 20147:00 amRNSHalf Yearly Report
24th Oct 20147:00 amRNSTrading Update and Notice of Interim Results
28th Aug 201412:39 pmRNSResult of AGM
1st Jul 20147:00 amRNSmHealth partnership in Sub-Saharan Africa
23rd Jun 20147:00 amRNSFinal Results
14th Apr 20147:00 amRNSTrading Update and Notice of Results
24th Mar 20144:34 pmRNSDirector/PDMR Shareholding
5th Mar 20142:38 pmRNSDirector/PDMR Shareholding
4th Mar 20143:07 pmRNSHolding(s) in Company
3rd Mar 201411:30 amRNSHolding(s) in Company
28th Feb 201412:42 pmRNSHolding(s) in Company
25th Feb 201411:38 amRNSGrant of Options
25th Feb 201410:06 amRNSCD4 - Grant of ARIPO Patent
24th Feb 20147:00 amRNSCD4 - UNITAID Grant Funding
24th Feb 20147:00 amRNSAllergy Development Update
21st Feb 20142:55 pmRNSHolding(s) in Company
13th Feb 20147:00 amRNSSuccessful completion of CD4 Technology Transfer
20th Dec 20137:00 amRNSCD4 Update
17th Dec 201310:27 amRNSHolding(s) in Company
27th Nov 20137:00 amRNSInterim Results
31st Oct 20137:00 amRNSCD4 Update
17th Oct 20137:00 amRNSTrading Update and Notice of Interim Results
26th Sep 20137:00 amRNSCD4 Update
28th Aug 201311:59 amRNSResult of AGM
17th Jul 201312:10 pmRNSHolding(s) in Company
15th Jul 201311:58 amRNSDirector/PDMR Shareholding
4th Jul 201311:22 amRNSGrant of Options
3rd Jul 20132:21 pmRNSHolding(s) in Company
1st Jul 20137:00 amRNSFinal Results
21st Jun 20137:00 amRNSAllergy Development Update
17th Jun 201310:03 amRNSHolding(s) in Company
10th Jun 201312:18 pmRNSResult of GM
24th May 20137:00 amRNSFundraising to raise £4 million
23rd Apr 20137:00 amRNSGrant of US Patent
22nd Apr 20137:00 amRNSDirectorate Change
10th Apr 20137:00 amRNSDistribution Agreement
10th Apr 20137:00 amRNSTrading Update and Notice of Results
4th Mar 20137:00 amRNSChange of Adviser
17th Dec 20127:00 amRNSChina approves Registration of Food Detective
13th Dec 20127:00 amRNSBanking Facilities increased
3rd Dec 20124:17 pmRNSHolding(s) in Company
21st Nov 20127:00 amRNSHalf Yearly Report
19th Nov 20127:00 amRNSGrant funding award
15th Oct 20127:00 amRNSAgreement with Super Religare Laboratories
15th Oct 20127:00 amRNSTrading Update & Notice of Results
28th Aug 201211:49 amRNSResult of AGM
23rd Jul 20127:00 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.